|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smith RA, von Eschenbach AC, Wender R,
Levin B, Byers T, Rothenberger D, Brooks D, Creasman W, Cohen C,
Runowicz C, et al: American Cancer Society guidelines for the early
detection of cancer: Update of early detection guidelines for
prostate, colorectal, and endometrial cancers. Also: Update
2001-testing for early lung cancer detection. CA Cancer J Clin.
51:38–75; quiz 77–80. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carpelan-Holmstrom M, Louhimo J, Stenman
UH, Alfthan H, Jarvinen H and Haglund C: CEA, CA 242, CA 19-9, CA
72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
Tumour Biol. 25:228–234. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hassan C, Pickhardt PJ, Laghi A, Kim DH,
Zullo A, Iafrate F, Di Giulio L and Morini S: Computed tomographic
colonography to screen for colorectal cancer, extracolonic cancer,
and aortic aneurysm: Model simulation with cost-effectiveness
analysis. Arch Intern Med. 168:696–705. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu X, Chen X, Zeng K, Xu M, He B, Pan Y,
Sun H, Pan B, Xu X and Xu T: DNA-methylation-mediated silencing of
miR-486-5p promotes colorectal cancer proliferation and migration
through activation of PLAGL2/IGF2/β-catenin signal pathways. Cell
Death Dis. 9:10372018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han LC, Wang H, Niu FL, Yan JY and Cai HF:
Effect miR-214-3p on proliferation and apoptosis of breast cancer
cells by targeting survivin protein. Eur Rev Med Pharmacol Sci.
23:7469–7474. 2019.PubMed/NCBI
|
|
7
|
Wei YQ, Jiao XL, Zhang SY, Xu Y, Li S and
Kong BH: MiR-9-5p could promote angiogenesis and radiosensitivity
in cervical cancer by targeting SOCS5. Eur Rev Med Pharmacol Sci.
23:7314–7326. 2019.PubMed/NCBI
|
|
8
|
Wu HY, Wei Y and Pan SL: Down-regulation
and clinical significance of miR-7-2-3p in papillary thyroid
carcinoma with multiple detecting methods. IET Syst Biol.
13:225–233. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
An HJ, Park M, Kim J and Han YH: miR5191
functions as a tumor suppressor by targeting RPS6KB1 in colorectal
cancer. Int J Oncol. Aug 30–2019.(Epub ahead of print). View Article : Google Scholar
|
|
10
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tang Y, Zhao Y, Song X, Song X, Niu L and
Xie L: Tumor-derived exosomal miRNA-320d as a biomarker for
metastatic colorectal cancer. J Clin Lab Anal. 33:e230042019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Sui J, Shen X, Li C, Yao W, Hong
W, Peng H, Pu Y, Yin L and Liang G: Differential expression
profiles of microRNAs as potential biomarkers for the early
diagnosis of lung cancer. Oncol Rep. 37:3543–3553. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu X, Xu T, Hu X, Chen X, Zeng K, Sun L
and Wang S: Elevated circulating miR-182 acts as a diagnostic
biomarker for early colorectal cancer. Cancer Manag Res.
10:857–865. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Usuba W, Urabe F, Yamamoto Y, Matsuzaki J,
Sasaki H, Ichikawa M, Takizawa S, Aoki Y, Niida S, Kato K, et al:
Circulating miRNA panels for specific and early detection in
bladder cancer. Cancer Sci. 110:408–419. 2019.PubMed/NCBI
|
|
15
|
Abu-Duhier FM, Javid J, Sughayer MA, Mir
R, Albalawi T and Alauddin MS: Clinical significance of circulatory
miRNA-21 as an efficient non-invasive biomarker for the screening
of lung cancer patients. Asian Pac J Cancer Prev. 19:2607–2611.
2018.PubMed/NCBI
|
|
16
|
Imaoka H, Toiyama Y, Fujikawa H, Hiro J,
Saigusa S, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, et al:
Circulating microRNA-1290 as a novel diagnostic and prognostic
biomarker in human colorectal cancer. Ann Oncol. 27:1879–1886.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu JH, Zuo ZX, Wang W, Zhao Q, Qiu MZ, Luo
HY, Chen ZH, Mo HY, Wang F, Yang DD, et al: A two-microRNA-based
signature predicts first-line chemotherapy outcomes in advanced
colorectal cancer patients. Cell Death Discov. 4:1162018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nonaka R, Nishimura J, Kagawa Y, Osawa H,
Hasegawa J, Murata K, Okamura S, Ota H, Uemura M, Hata T, et al:
Circulating miR-199a-3p as a novel serum biomarker for colorectal
cancer. Oncol Rep. 32:2354–2358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ho AS, Kim S, Tighiouart M, Gudino C, Mita
A, Scher KS, Laury A, Prasad R, Shiao SL, Ali N, et al: Association
of quantitative metastatic lymph node burden with survival in
hypopharyngeal and laryngeal cancer. JAMA Oncol. 4:985–989. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zou X, Li M, Huang Z, Zhou X, Liu Q, Xia T
and Zhu W: Circulating miR-532-502 cluster derived from chromosome
X as biomarkers for diagnosis of breast cancer. Gene.
722:1441042020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
D'Antona P, Cattoni M, Dominioni L, Poli
A, Moretti F, Cinquetti R, Gini E, Daffre E, Noonan DM, Imperatori
A, et al: Serum miR-223: A validated biomarker for detection of
early-stage non-small cell lung cancer. Cancer Epidemiol Biomarkers
Prev. 28:1926–1933. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cui Q: Significance of miR-27a and miR-31
in early diagnosis and prognosis of colorectal cancer. Oncol Lett.
18:3092–3096. 2019.PubMed/NCBI
|
|
24
|
Smith RA, Andrews KS, Brooks D, Fedewa SA,
Manassaram-Baptiste D, Saslow D, Brawley OW and Wender RC: Cancer
screening in the United States, 2017: A review of current American
Cancer Society guidelines and current issues in cancer screening.
CA Cancer J Clin. 67:100–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Raju GS, Chang DW, Lin SH, Chen Z
and Wu X: Global and targeted circulating microRNA profiling of
colorectal adenoma and colorectal cancer. Cancer. 124:785–796.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hou W, Zhang H, Bai X, Liu X, Yu Y, Song L
and Du Y: Suppressive role of miR-592 in breast cancer by
repressing TGF-β2. Oncol Rep. 38:3447–3454. 2017.PubMed/NCBI
|
|
27
|
He Y, Ge Y, Jiang M, Zhou J, Luo D, Fan H,
Shi L, Lin L and Yang L: MiR-592 promotes gastric cancer
proliferation, migration, and invasion through the PI3K/AKT and
MAPK/ERK signaling pathways by targeting spry2. Cell Physiol
Biochem. 47:1465–1481. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li Z, Li B, Niu L and Ge L: miR-592
functions as a tumor suppressor in human non-small cell lung cancer
by targeting SOX9. Oncol Rep. 37:297–304. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gao S, Chen J, Wang Y, Zhong Y, Dai Q,
Wang Q and Tu J: MiR-592 suppresses the development of glioma by
regulating Rho-associated protein kinase. Neuroreport.
29:1391–1399. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fu Q, Du Y, Yang C, Zhang D, Zhang N, Liu
X, Cho WC and Yang Y: An oncogenic role of miR-592 in tumorigenesis
of human colorectal cancer by targeting Forkhead Box O3A (FoxO3A).
Expert Opin Ther Targets. 20:771–782. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu M, Zhi Q, Wang W, Zhang Q, Fang T and
Ma Q: Up-regulation of miR-592 correlates with tumor progression
and poor prognosis in patients with colorectal cancer. Biomed
Pharmacother. 69:214–220. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Carpelan-Holmstrom M, Louhimo J, Stenman
UH, Alfthan H and Haglund C: CEA, CA 19-9 and CA 72-4 improve the
diagnostic accuracy in gastrointestinal cancers. Anticancer Res.
22:2311–2316. 2002.PubMed/NCBI
|
|
33
|
Sun L, Liu X, Pan B, Hu X, Zhu Y, Su Y,
Guo Z, Zhang G, Xu M, Xu X, et al: Serum exosomal miR-122 as a
potential diagnostic and prognostic biomarker of colorectal cancer
with liver metastasis. J Cancer. 11:630–637. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zeng Z, Li Y, Pan Y, Lan X, Song F, Sun J,
Zhou K, Liu X, Ren X, Wang F, et al: Cancer-derived exosomal
miR-25-3p promotes pre-metastatic niche formation by inducing
vascular permeability and angiogenesis. Nat Commun. 9:53952018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu B, Su S, Patil DP, Liu H, Gan J,
Jaffrey SR and Ma J: Molecular basis for the specific and
multivariant recognitions of RNA substrates by human hnRNP A2/B1.
Nat Commun. 9:4202018. View Article : Google Scholar : PubMed/NCBI
|
